On August 25, 2021, Mr. Assaf Korner, Chief Financial Officer of Bellerophon Therapeutics, Inc. (the Company"), notified the Company of his intent to resign as Chief Financial Officer and from all other positions held with the Company. Mr. Korner's effective resignation date is September 10, 2021.